Analisis Faktor yang Berhubungan dengan Length of Stay (LOS) Pasien Demam Berdarah Dengue (A91) di Rumah Sakit Citra Husada Jember
DOI:
https://doi.org/10.25047/j-remi.v7i3.6713Keywords:
Dengue Hemorrhagic Fever, Length of Stay, Medical RecordAbstract
Length of Stay (LOS) at Citra Husada Hospital frequently exceeds the established standard of seven days. Over the past two years, Dengue Hemorrhagic Fever (DHF) cases have increased by 71.1% and ranked among the top ten causes of inpatient admissions in 2024. Prolonged LOS may increase healthcare costs, whereas excessively short LOS may lead to readmission. This study aimed to identify factors associated with LOS among DHF patients. A quantitative cross-sectional design was employed involving 450 adult DHF patients, with 208 electronic medical records selected through simple random sampling. Data were analyzed using univariate and bivariate analyses with the chi-square test. The results showed that age (p < 0.001), comorbidity (p < 0.001), and nutritional status (p = 0.042) were significantly associated with LOS. In contrast, sex (p = 0.850), platelet count (p = 0.190), leukocyte count (p = 0.157), and hematocrit level (p = 0.090) were not significantly associated with LOS. Adult DHF patients with comorbidities and abnormal nutritional status were more likely to experience prolonged LOS. Hospitals should develop clinical pathways and provide targeted education to reduce the risk of prolonged hospitalization.
References
[1] A. E. Suryandari and T. Anasari, “Faktor-Faktor yang Mempengaruhi Lama Perawatan Pasien Demam Berdarah Dengue,” J. Bidan Prada, vol. 13, no. 1, pp. 47–56, 2022.
[2] O. J. Sumampouw, “Epidemiologi Demam Berdarah Dengue di Kabupaten Minahasa Sulawesi Utara,” Sam Ratulangi J. Public Heal., vol. 1, no. 1, pp. 1–8, Jan. 2020, doi: 10.35801/srjoph.v1i1.27272.
[3] Kementerian Kesehatan Republik Indonesia, Profil Kesehatan Indonesia Tahun 2023. Jakarta: Kementerian Kesehatan Republik Indonesia, 2023.
[4] S. Cahyani, T. Rizkianti, and T. Susantiningsih, “Hubungan Jumlah Trombosit, Nilai Hematokrit dan Rasio Neutrofil-Limfosit Terhadap Lama Rawat Inap Pasien DBD,” in Seminar Nasional Riset Kedokteran (SENSORIK) 2020, UPN Veteran Jakarta, 2020, pp. 49–59.
[5] Kementerian Kesehatan Republik Indonesia, Pedoman Pencegahan dan Pengendalian Demam Berdarah Dengue di Indonesia. Jakarta: Kementerian Kesehatan Republik Indonesia, 2017.
[6] S. Alfiana, “Hubungan Jumlah Leukosit dan Trombosit terhadap Lama Rawat Inap Pasien DBD Anak di RSUD Dr. Harjono Ponorogo,” Universitas Muhammadiyah Surakarta, 2019.
[7] R. A. Putra, R. Sofia, and W. P. Mellaratna, “Faktor-Faktor yang Mempengaruhi Lama Rawat Inap pada Pasien Demam Berdarah Dengue di Rumah Sakit Umum Cut Meutia,” J. Med. Nusant., vol. 4, no. 1, pp. 65–73, Jan. 2026, doi: 10.59680/medika.v4i1.2184.
[8] C. E. D. Sari, “Hubungan Parameter Laboratorium dengan Lama Rawat Inap pada Pasien Demam Berdarah Dengue,” Universitas Islam Sultan Agung, 2023.
[9] I. Perwira, “Faktor faktor yang mempengaruhi lama rawat inap pada pasien yang terinfeksi virus dengue di RSUP persahabatan, jakarta timur,” Universitas Indonesia, 2011.
[10] S. F. Khairunnisa, S. Wahyu, S. W. Gayatri B., A. Safitri, and A. I. Arfah, “Hubungan Status Gizi Dengan Kejadian Penyakit Demam Berdarah Dengue (DBD) Pada Anak Di RS Ibnu Sina Tahun 2021 - 2023,” Borneo J. Med. Lab. Technol., vol. 8, no. 1, pp. 828–836, Nov. 2025, doi: 10.33084/bjmlt.v8i1.9666.
[11] L. S. Nabila, Sulistiawati, Bramantono, and U. Maimunah, “Comorbid Factors and Duration of Illness in Dengue Hemorrhagic Fever Patients at Universitas Airlangga Hospital, Surabaya, Indonesia,” J. Community Med. Public Heal. Res., vol. 5, no. 1, pp. 71–78, May 2024, doi: 10.20473/jcmphr.v5i1.52966.
[12] H. Nopianto, “Faktor-Faktor yang Berpengaruh terhadap Lama Rawat Inap pada Pasien Demam Berdarah Dengue di RSUP Dr Kariadi Semarang,” Universitas Diponegoro, 2012.
[13] Sugiyono, Metode Penelitian Kuantitatif Kualitatif, dan R&D. Bandung: Alfabeta, 2017.
[14] M. S. Dahlan, Statistik Untuk Kedokteran Dan Kesehatan, Edisi 3. Jakarta: Salemba Medika, 2008.
[15] R. A. Khoiro, G. Nugraha, and W. Sriwulan, “Pengaruh Lama Perawatan Terhadap Indeks Platelet Pasien Demam Berdarah Dengue (DBD) Di Rumah Sakit Islam Jemursari Surabaya,” Med. Technol. Public Heal. J., vol. 5, no. 1, pp. 85–91, Apr. 2021, doi: 10.33086/mtphj.v5i1.1150.
[16] M. A. Sugianto, “Strategi Pencegahan dan Pengendalian DBD (Kasus di Kecamatan Kuta Utara Kabupaten Badung),” Bappenas Work. Pap., vol. 6, no. 1, pp. 141–154, Mar. 2023, doi: 10.47266/bwp.v6i1.184.
[17] A. I. Tarigan, R. Alexander, and O. Natali, “Karakteristik Demam Berdarah Dengue Pada Anak Di Rumah Sakit Umum Royal Prima Medan,” J. Kesmas Prima Indones., vol. 3, no. 1, pp. 42–46, Feb. 2022, doi: 10.34012/jkpi.v3i1.1783.
[18] N. Ermawati, E. Erawati, and Y. T. Ismawanti, “Hubungan Nilai Hematokrit dengan Jumlah Eritrosit pada Pasien Demam Dengue di Rumah Sakit Bhayangkara Kota Kediri,” J. Anestesi, vol. 3, no. 1, pp. 59–67, Dec. 2024, doi: 10.59680/anestesi.v3i1.1593.
[19] S. Abdu, “Analisis Faktor Risiko Laboratories Kejadian Sindrom Syok Dengue Pada Pasien Demam Berdarah Dengue,” J. Keperawatan Florence Nightingale, vol. 2, no. 1, pp. 25–38, 2019.
[20] O. Marpaung, I. Jayanti, and R. A. C. Saragih, “Hubungan Jumlah Leukosit dan Trombosit terhadap Lama Rawat Inap Pasien Demam Berdarah Dengue Anak di RSUD Drs. H. Amri Tambunan Deli Serdang,” Nommensen J. Med., vol. 9, no. 2, pp. 83–88, Feb. 2024, doi: 10.36655/njm.v9i2.1004.
[21] D. P. S. A. Kunti and K. Suryana, “Factors associated with prolonged length of stay in dengue hemorrhagic fever patients at Wangaya Hospital, Denpasar, Bali,” Int. J. Adv. Med., vol. 11, no. 4, pp. 328–332, Jun. 2024, doi: 10.18203/2349-3933.ijam20241624.
[22] S. Mishra, D. Chopra, N. Jauhari, and A. Ahmad, “A study on length of stay and its predictors among dengue patients in a tertiary care institute in Lucknow,” Int. J. Community Med. Public Heal., vol. 6, no. 11, pp. 4870–4875, Oct. 2019, doi: 10.18203/2394-6040.ijcmph20195071.
[23] V. P. K. Tan et al., “The association between obesity and dengue virus (DENV) infection in hospitalised patients,” PLoS One, vol. 13, no. 7, pp. 1–14, Jul. 2018, doi: 10.1371/journal.pone.0200698.
[24] R. J. Lin, T. H. Lee, and Y. S. Leo, “Dengue in the elderly: a review,” Expert Rev. Anti. Infect. Ther., vol. 15, no. 8, pp. 729–735, Aug. 2017, doi: 10.1080/14787210.2017.1358610.
[25] E. Mocchegiani, “Zinc and ageing: third Zincage conference,” Immun. Ageing, vol. 4, no. 1, pp. 1–7, Dec. 2007, doi: 10.1186/1742-4933-4-5.
[26] D. A. Frey, Harrison’s Principles Of Internal Medicine 15th Edition, 15th Edition. New York: The McGraw-Hill Companies, 2001.
[27] Kementerian Kesehatan Republik Indonesia, Keputusan Menteri Kesehatan Republik Indonesia HK.01.07/MENKES/9845/2020 Tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Infeksi Dengue Pada Dewasa. Jakarta: Kementerian Kesehatan Republik Indonesia, 2020.
[28] D. putri A. Islammia, N. A. Rumana, L. Indawati, and D. R. Dewi, “Karakteristik Pasien Demam Berdarah Dengue Rawat Inap di Rumah Sakit Umum UKI Tahun 2020,” SEHATMAS J. Ilm. Kesehat. Masy., vol. 1, no. 1, pp. 60–70, Jan. 2022, doi: 10.55123/sehatmas.v1i1.37.
[29] M. D. Arianti, J. Prijambodo, and H. Wujoso, “Relationships between Age, Sex, Laboratory Parameter, and Length of Stay in Patients with Dengue Hemorrhagic Fever,” J. Epidemiol. Public Heal., vol. 4, no. 4, pp. 307–313, 2019, doi: 10.26911/jepublichealth.2019.04.04.05.
[30] F. P. Dewandaru and W. Suryanegara, “Hubungan Lama Rawat Inap Pasien Demam Berdarah Dengue Anak dengan Hasil Pemeriksaan Darah Tepi di RSU UKI,” Maj. Kedokt. UKI, vol. XXXIX, no. 11, pp. 7–10, 2023.
[31] R. I. Tuzzahra, “Hubungan Beberapa Parameter Hematologi dengan Lama Rawat Inap Pasien Demam Berdarah Dengue (DBD) Dewasa di Rumah Sakit Umum (RSU) Kota Tangerang Selatan Tahun 2014-2015,” Universitas Islam Negeri Syarif Hidayatullah, 2016.
[32] Kementerian Kesehatan Republik Indonesia, Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/4636/2021 Tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Infeksi Dengue Anak dan Remaja. Jakarta: Kementerian Kesehatan Republik Indonesia, 2021.
[33] H. Puerta-Guardo, D. R. Glasner, and E. Harris, “Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability,” PLOS Pathog., vol. 12, no. 7, pp. 1–29, Jul. 2016, doi: 10.1371/journal.ppat.1005738.
[34] T. H. Mallhi, A. H. Khan, A. S. Adnan, A. Sarriff, Y. H. Khan, and F. Jummaat, “Incidence, Characteristics and Risk Factors of Acute Kidney Injury among Dengue Patients: A Retrospective Analysis,” PLoS One, vol. 10, no. 9, pp. 1–16, Sep. 2015, doi: 10.1371/journal.pone.0138465.
[35] Pan American Health Organization and WHO, Algorithms for the Clinical Management of Dengue Patients. WHO, 2020.
[36] U. M. M. Djawa, “Hubungan Status Gizi dengan Lama Rawat Inap Pasien DBD Anak di RSK Lindimara Sumba Timur Tahun 2019,” Univeristas Kristen Duta Wacana, 2021.
[37] M. A. M. Khalil, J. Tan, M. A. U. Khalil, S. Awan, and M. Rangasami, “Predictors of hospital stay and mortality in dengue virus infection-experience from Aga Khan University Hospital Pakistan,” BMC Res. Notes, vol. 7, no. 1, pp. 1–7, Dec. 2014, doi: 10.1186/1756-0500-7-473.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Putri Nur Hidayah, Efri Tri Ardianto
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
